Abstract
Fibromyalgia (FM) is a syndrome characterized by chronic widespread pain and the presence of specific tender points. The prevalence of FM has been estimated at 2–7 % of the general global population. The presence of FM in several rheumatic diseases with a structural pathology has been reported as 11–30 %. The objectives of this study were to determine the prevalence of FM and to evaluate the possible relationship between FM existence and disease activity among rheumatic diseases. The study group included 835 patients—197 rheumatoid arthritis (RA), 67 systemic lupus erythematosus (SLE), 119 ankylosing spondylitis (AS), 238 osteoarthritis (OA), 14 familial Mediterranean fever (FMF), 53 Behçet’s disease (BD), 71 gout, 25 Sjögren’s syndrome (SS), 20 vasculitis, 29 polymyalgia rheumatica (PMR), and two polymyositis (PM)—with or without FM. Recorded information included age, gender, laboratory parameters, presence of fatigue, and disease activity indexes. The prevalence of FM in patients with rheumatologic diseases was found to be 6.6 % for RA, 13.4 % for SLE, 12.6 % for AS, 10.1 % for OA, 5.7 % for BD, 7.1 % for FMF, 12 % for SS, 25 % for vasculitis, 1.4 % for gout, and 6.9 % for PMR. One out of two patients with PM was diagnosed with FM. Some rheumatologic cases (AS, OA) with FM were observed mostly in female patients (p = 0.000). Also, there were significant correlations between disease activity indexes and Fibromyalgia Impact Questionnaire scores for most rheumatologic patients (RA, AS, OA, and BD) (p < 0.05; respectively, r = 0.6, 0.95, 0.887, and 1). Concomitant FM is a common clinical problem in rheumatologic diseases, and its recognition is important for the optimal management of these diseases. Increased pain, physical limitations, and fatigue may be interpreted as increased activity of these diseases, and a common treatment option is the prescription of higher doses of biologic agents or corticosteroids. Considerations of the FM component in the management of rheumatologic diseases increase the likelihood of the success of the treatment.
Similar content being viewed by others
References
Wolfe F, Ross K, Anderson J, Russell IJ, Hebert L (1995) The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum 38:19–28
Assumpção A, Cavalcante AB, Capela CE, Sauer JF, Chalot SD, Pereira CA, Marques AP (2009) Prevalence of fibromyalgia in a low socioeconomic status population. BMC Musculoskelet Disord 10:64
Branco JC, Bannwarth B, Failde I, Abello Carbonell J, Blotman F, Spaeth M et al (2010) Prevalence of fibromyalgia: a survey in five European countries. Semin Arthritis Rheum 39(6):448–453
Yunus MB (2012) The prevalence of fibromyalgia in other chronic pain conditions. Pain Res Treat. doi:10.1155/2012/584573
Hawker GA, French MR, Waugh EJ, Gignac MAM, Cheung C, Murray BJ (2010) The multidimensionality of sleep quality and its relationship to fatigue in older adults with painful osteoarthritis. Osteoarthr Cartil 18:1365–1371
Azevedo VF, Paiva ES, Felippe LRH, Moreira RA (2010) Occurrence of fibromyalgia in patients with ankylosing spondylitis. Bras J Rheumatol 50(6):646–654
Wolfe F, Petri M, Alarcón GS, Goldman J, Chakravarty EF, Katz RS, Karlson EW, Michaud K (2009) Fibromyalgia, systemic lupus erythematosus (SLE) and the evaluation of SLE activity. J Rheumatol 36(1):82–88
Pollard LC, Kingsley GH, Choy EH, Scott DL (2010) Fibromyalgic rheumatoid arthritis and disease assessment. Rheumatology 49:924–928
Ranzolin A, Brenol JCT, Bredemeier M, Guarienti J, Rizzatti M, Feldman D, Xavier RM (2009) Association of concomitant fibromyalgia with worse disease activity score in 28 joints, Health Assessment Questionnaire, and short form 36 scores in patients with rheumatoid arthritis. Arthritis Rheum 61(6):794–800
Melikoglu M, Melikoglu MA (2012) The prevalence of fibromyalgia in patients with Behçet’s disease and its relation with disease activity. Rheumatol Int. doi:10.1007/s00296-012-2530-1
Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–324
Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF et al (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271–1277
Bennet PM, Wood PHN (1966) Recommendations—ankylosing spondylitis. In: Bennet PM, Wood PHN (eds) Population studies of the rheumatic diseases. International congress series no. 148. Excerpta Medica, Amsterdam, pp 456–457
Altman RD (1991) Criteria for classification of clinical osteoarthritis. J Rheumatol 18(27):10–12
Livneh A, Langevitz P, Zemer D, Zaks N, Kees S, Lidar T et al (1997) Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum 40(10):1879–1985
International Study Group for Behcet’s Disease (1990) Criteria for the diagnosis of Behcet’s disease. Lancet 335:1078–1080
Wallace SL, Robinson H, Masi AT, Decler JL, McCarty DJ, Yü TF (1977) Preliminary criteria for the classification of acute arthritis of primary gout. Arthritis Rheum 20:895–900
Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE et al (2002) Classification criteria for Sjögren’s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 61(6):554–558
Jenette JC, Falk RJ, Androssy K, Bacon PA, Churg J, Gross WL et al (1994) Nomenclature of systemic vasculitides: proposal of an interrational consensus conference. Arthritis Rheum 37:187–192
Healey LA (1984) Long-term follow-up of PMR: evidence for synovitis. Semin Arthritis Rheum 13(4):322–328
Chuang TY, Hunder GG, Ilstrup DM, Kurland LT (1982) Polymyalgia rheumatica: a 10-year epidemiologic and clinical study. Ann Intern Med 97(5):672–680
Bohan A, Peter JB (1975) Polymyositis and dermatomyositis. N Engl J Med 292:344–347
Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL et al (1990) The American College of Rheumatology 1990 criteria for the classification of fibromyalgia: report of the Multicenter Criteria Committee. Arthritis Rheum 33(2):160–172
Jahan F, Nanji K, Qidwai W, Qasim R (2012) Fibromyalgia syndrome: an overview of pathophysiology, Diagnosis and Management. Oman Med J 27(3):192–195
Sarmer S, Ergin S, Yavuzer G (2000) The validity and reliability of the Turkish version of the Fibromyalgia Impact Questionnaire. Rheumatol Int 20:9–12
Burckhardt CS, Clark SR, Bennett RM (1991) The fibromyalgia impact questionnaire: development and validation. J Rheumatol 18:728–733
Garret S, Jenkinson T, Kennedy L, Whitelock H, Gaisford P, Calin A (1994) A new approach to deWning disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 21:2286–2291
Akkoc Y, Karatepe AG, Akar S, Kirazli Y, Akkoc N (2005) A Turkish version of the Bath Ankylosing Spondylitis Disease Activity Index: reliability and validity. Rheumatol Int 25(4):280–284
Tuzun EH, Eker L, Aytar A, Daşkapan A, Bayramoğlu M (2005) Acceptability, reliability, validity and responsiveness of the Turkish version of WOMAC osteoarthritis index. Osteoarthr Cartil 13(1):28–33
Bellamy N, Buchanan WW, Goldsmith CH, Campbell J, Stitt LW (1988) Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol 15(12):1833–1840
Mor A, Shinar Y, Zaks N, Langevitz P, Chetrit A, Shtrasburg S, Rabinovitz E, Livneh A (2005) Evaluation of disease severity in familial Mediterranean fever. Semin Arthritis Rheum 35(1):57–64
Bhakta BB, Brennan P, James TE, Chamberlain MA et al (1999) Behçet’s disease: evaluation of a new instrument to measure clinical activity. Rheumatology 38:728–733
Hamuryudan V, Fresko I, Direskeneli H, Tennant MJ et al (1999) Evaluation of the Turkish translation of a disease activity form for Behçet’s syndrome. Rheumatology 38:734–736
Arnold LM, Clauw DJ, McCarberg BH (2011) Improving the recognition and diagnosis of fibromyalgia. Mayo Clin Proc 86:457–464
Wolfe F, Michaud K (2004) Severe rheumatoid arthritis, worse outcomes, comorbid illness and sociodemographic disadvantage characterize RA patients with fibromyalgia. J Rheumatol 31(4):695–700
Wolfe F, Häuser W, Hassett AL, Katz RS, Walitt BT (2011) The development of fibromyalgia—I: examination of rates and predictors in patients with rheumatoid arthritis (RA). Pain 152:291–299
Valencia-Flores M, Cardiel MH, Santiago V, Resendiz M, Castaño VA, Negrete O, Rosenberg C, García-Ramos G, Alcocer J, Alarcón-Segovia D (2004) Prevalence and factors associated with fibromyalgia in Mexican patients with systemic lupus erythematosus. Lupus 13(1):4–10
Buskila D, Press J, Abu-Shakra M (2003) Fibromyalgia in systemic lupus erythematosus: prevalence and clinical implications. Clin Rev Allergy Immunol 25(1):25–28
Friedman AW, Tewi MB, Ahn C, McGwin G Jr, Fessler BJ, Bastian HM, Baethge BA, Reveille JD, Alarcón GS, LUMINA Study Group (2003) Systemic lupus erythematosus in three ethnic groups: XV prevalence and correlates of fibromyalgia. Lupus 12(4):274–279
Almodóvar R, Carmona L, Zarco P, Collantes E, González C, Mulero J et al (2010) Fibromyalgia in patients with ankylosing spondylitis: prevalence and utility of the measures of activity, function and radiological damage. Clin Exp Rheumatol 28(6 Suppl 63):33–39
Aloush V, Ablin JN, Reitblat T, Caspi D, Elkayam O (2007) Fibromyalgia in women with ankylosing spondylitis. Rheumatol Int 27(9):865–868
Giles I, Isenberg D (2000) Fatigue in primary Sjögren’s syndrome: is there a link with the fibromyalgia syndrome? Ann Rheum Dis 59:875–878
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Haliloglu, S., Carlioglu, A., Akdeniz, D. et al. Fibromyalgia in patients with other rheumatic diseases: prevalence and relationship with disease activity. Rheumatol Int 34, 1275–1280 (2014). https://doi.org/10.1007/s00296-014-2972-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-014-2972-8